| Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi AA Robinson, CR Trankle, G Eubanks, C Schumann, P Thompson, ... JAMA cardiology 5 (6), 685-692, 2020 | 201 | 2020 |
| Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial) BW Van Tassell, J Canada, S Carbone, C Trankle, L Buckley, ... Circulation: Heart Failure 10 (11), e004373, 2017 | 186 | 2017 |
| Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ... Journal of the American Heart Association 9 (5), e014941, 2020 | 180 | 2020 |
| Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies) A Abbate, MC Kontos, NA Abouzaki, RD Melchior, C Thomas, ... The American journal of cardiology 115 (3), 288-292, 2015 | 165 | 2015 |
| IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 146 | 2018 |
| Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study BW Van Tassell, NA Abouzaki, CO Erdle, S Carbone, CR Trankle, ... Journal of cardiovascular pharmacology 67 (6), 544-551, 2016 | 122 | 2016 |
| Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2) BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ... Clinical cardiology 40 (9), 626-632, 2017 | 116 | 2017 |
| Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction S Carbone, JM Canada, LF Buckley, CR Trankle, HE Billingsley, ... Basic to Translational Science 2 (5), 513-525, 2017 | 98 | 2017 |
| IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB/II pilot study CR Trankle, JM Canada, D Kadariya, R Markley, HM De Chazal, J Pinson, ... American journal of respiratory and critical care medicine 199 (3), 381-384, 2019 | 80 | 2019 |
| Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with … GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, S Carbone, ... Journal of cardiovascular pharmacology 77 (1), 49-60, 2021 | 73 | 2021 |
| Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction S Carbone, JM Canada, LF Buckley, CR Trankle, DL Dixon, R Buzzetti, ... Journal of the American College of Cardiology 68 (22), 2487-2488, 2016 | 58 | 2016 |
| Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein CR Trankle, JM Canada, L Cei, N Abouzaki, C Oddi-Erdle, D Kadariya, ... The American journal of cardiology 122 (8), 1366-1370, 2018 | 56 | 2018 |
| Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials A Abbate, GF Wohlford, MG Del Buono, JG Chiabrando, R Markley, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 503-510, 2022 | 54 | 2022 |
| Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction LF Buckley, JM Canada, MG Del Buono, S Carbone, CR Trankle, ... ESC heart failure 5 (2), 372-378, 2018 | 53 | 2018 |
| A review of PCSK9 inhibition and its effects beyond LDL receptors DL Dixon, C Trankle, L Buckley, E Parod, S Carbone, BW Van Tassell, ... Journal of clinical lipidology 10 (5), 1073-1080, 2016 | 53 | 2016 |
| Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ... Clinical cardiology 41 (8), 1004-1008, 2018 | 50 | 2018 |
| Canada JM, Carbone S, Buckley L, Kadariya D, et al BW Van Tassell, CR Trankle IL-1 blockade in patients with heart failure with preserved ejection …, 2018 | 48 | 2018 |
| Canada LF Buckley, S Carbone, CR Trankle JM, Del Buono, MG, Carbone, S., Trankle, CR, Billingsley, H., Kadariya, D …, 2018 | 47 | 2018 |
| Acute myocarditis associated with desmosomal gene variants E Ammirati, F Raimondi, N Piriou, L Sardo Infirri, SA Mohiddin, A Mazzanti, ... Heart Failure 10 (10), 714-727, 2022 | 46 | 2022 |
| Canada, JM; Carbone, S.; Roberts, CS; Abouzaki, N.; et al. Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial … A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya J. Am. Heart Assoc 9, e014941, 2020 | 42 | 2020 |
Antonio AbbateProfessor of Cardiology, University of VirginiaVerified email at virginia.edu
